ReShape Lifesciences

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.

New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding

ReShape Lifesciences™ Receives FDA 510(k) Clearance for the GIBI HD™ Calibration Tubes for use in Gastric and Bariatric Procedures

SAN CLEMENTE, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has appointed Paul F. Hickey as President and Chief Executive Officer and as a member of the Board of Directors, effective August 15, 2022. Mr. Hickey succeeds Bart Bandy, who has separated from the company to pursue other opportunities. Thomas Stankovich, Chief Financial Officer of ReShape, will serve as Interim President and Chief Executive Officer until Mr. Hickey joins the company. Dan W. Gladney, current Chair of the Board of Directors, will assume a more active role as Executive Chair, supporting Mr. Hickey and the company on strategic matters.

ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer

SAN CLEMENTE, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, announced today that it has entered into a warrant exercise agreement with an existing accredited investor to exercise outstanding warrants to purchase up to an aggregate of 3.7 million shares of the company's common stock. In consideration for the immediate exercise of the existing warrants for cash, the exercising holder received new unregistered warrants to purchase up to an aggregate of 3.7 million shares (equal to 100% of the shares of common stock issued in connection with the exercise) of the company's common stock. In connection with the exercise, the company also agreed to reduce the exercise price of the 3.7 million exercised warrants and 1.6 million remaining unexercised warrants to $0.6665, which is equal to the most recent closing price of the company's common stock on The Nasdaq Capital Market prior to the execution of the warrant exercise agreement.

ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds

Solution will Provide Physician-Led Virtual Weight Loss Coaching Solution will Provide Physician-Led Virtual Weight Loss Coaching

ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™

ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q1 2022 Earnings Conference Call May 23, 2022 8:30 AM ET Company Participants Michael Miller - Rx Communications, Investor Relations Bart Bandy - President and Chief Executive Officer Tom Stankovich - Chief Financial Officer Conference Call Participants Operator Good day and thank you for standing by. Welcome to the ReShape Lifesciences First Quarter 2022 Earnings Webcast.

ReShape Lifesciences Inc.'s (RSLS) CEO Bart Bandy on Q1 2022 Results - Earnings Call Transcript

March 2022 Revenues Exceeded January's and February's, Combined, Indicating DTC Campaign and Other Visibility Activities are Driving Significant Demand for Lap-Band® Procedures

ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update

SAN CLEMENTE, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Vernon “Vern” Vincent, the company's Senior Director, Global Professional Education and Medical Affairs, will be recognized as this year's Distinguished Industry Partner at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2022 LEAD Gala and Awards, to be held Wednesday, June 8, 2022 in Dallas, Texas.

ReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards

Webcast to be Held at 8:30 am ET on Monday, May 23, 2022 Webcast to be Held at 8:30 am ET on Monday, May 23, 2022

ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update

Management will also Present to Members of the Philadelphia Securities Association Management will also Present to Members of the Philadelphia Securities Association

ReShape Lifesciences to Present at the Q2 Investor Summit

ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q4 2021 Results - Earnings Call Transcript

Conference Call to be Held at 5:30 pm ET Today Conference Call to be Held at 5:30 pm ET Today

ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update

New Generation of Patients are Engaged as E videnced by Surge in Website Traffic and Doctor Referrals

ReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band®

Full Year Revenue Increased by Approximately 20%, from $11.3 M to $13.6 M

ReShape Lifesciences™ to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update

Company to Present and Exhibit its Next-Generation Lap-Band® Program Including its Supportive r e s hape c are ™ Virtual Health Coaching Platform

ReShape Lifesciences™ to Participate in the American Society for Metabolic and Bariatric Surgery's (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegas

Seasoned Executive Brings Significant Operational and Commercial Experience to Accelerate the Company's Growth Seasoned Executive Brings Significant Operational and Commercial Experience to Accelerate the Company's Growth

ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations

BEST Inc - ADR

GSX Techedu Inc.

Here's three penny stocks to add to your list for next week The post 3 Hot Penny Stocks to Add to Your Watchlist This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks to Add to Your Watchlist This Week

Alzamend Neuro

Cellectar BioSciences

Mustang Bio

X4 Pharmaceuticals Inc

5 penny stocks to watch this week The post Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week

The stock price of ReShape Lifesciences Inc (NASDAQ: RSLS) increased by over 19% pre-market today. This is why it happened.

ReShape Lifesciences Stock (RSLS): Why The Price Surged Today

SAN CLEMENTE, Calif., Dec. 9, 2021 /PRNewswire/ -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that Bart Bandy, Chief Executive Officer and President and Tom Stankovich, Chief Financial Officer of ReShape Lifesciences, will present a company overview live at VirtualInvestorConferences.com, at 2:00 pm ET on December 16 th.

ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16th

National advertising campaign and Virtual Media Tour achieve all key performance indicators National advertising campaign and Virtual Media Tour achieve all key performance indicators

ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign

ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q3 2021 Results - Earnings Call Transcript

Webinar to follow at 8:45 a.m. ET today Webinar to follow at 8:45 a.m. ET today

ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results

SAN CLEMENTE, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced today that it will report its third quarter 2021 financial and operational results on Thursday, November 11, 2021 at 8:30 a.m. ET.

ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021

SAN CLEMENTE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced Thomas Stankovich, Chief Financial Officer of the Company, will present at the Annual Small Cap Growth Conference hosted by Dawson James Securities on October 21, 2021, at the Wyndham Grand Hotel in Jupiter, Florida.

ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference

ZW Data Action Technologies Inc.

Federal National Mortgage Association

Are these penny stocks worth watching right now? The post Popular Penny Stocks to Buy in October?

News for ReShape Lifesciences Stock (RSLS)